Should I buy Synopsys (SNPS) stock or is it too late?

Synopsys · Information Technology · price $465

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Rosenblatt — 73% of its targets hit on this sector (545 calls tested). It aims for $575 (+24 %), call made on August 26, 2026, maturing on August 26, 2027 (2 d ago).

The 5 reliable analysts $550+18 %

The 5 other firms $600+29 %

How to read it: the 5 reliable firms are not filtered by optimism — 4 aim above the price, 1 below, hence their $550 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Synopsys

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	85 %	+28.6 %	20	$450 -3%
Keybanc	84 %	+25.5 %	31	$600 +29%
Baird	76 %	+25.2 %	21	$535 +15%
JP Morgan	75 %	+23.9 %	8	$650 +40%
B of A Securities	89 %	+18.4 %	19	$600 +29%
Stifel	100 %	+13.9 %	6	$600 +29%
Rosenblatt	67 %	+12.7 %	27	$575 +24%
Needham	62 %	+11.8 %	24	$580 +25%

In short — Should you invest in Synopsys? Is it too late, still worth it? Analysts are fairly positive (70% buy, median target $573, i.e. +23%), and the most reliable on SNPS targets even higher. But the valuation is stretched (P/E ~71), the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

70% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
Median price target $573, i.e. +23% from the current price ($465).
The most reliable firm on SNPS, Stifel (100% hit rate, 6 scored calls), targets $600 (call made on May 28, 2026, maturing on May 28, 2027) (+29%) in its most recent call, and $550 (call made on September 10, 2025, maturing on September 10, 2026) (+18%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 2 are neutral and 1 is a sell.
High valuation (P/E ~71): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on SNPS

Median target $573 (+23%) · 10 ratings · Buy consensus

Strong Buy00%

Buy770%

Hold220%

Sell110%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Synopsys now?

We won't decide for you. The facts: 70% of analysts rate it a buy, median target $573 (+23%), and Stifel (most reliable on SNPS, 100%) targets $600. Weigh that against valuation (P/E ~71) and volatility. This is not personalized advice.

Is it too late to invest in Synopsys?

Not according to analysts: the median target ($573) is still +23% above the current price ($465) (most reliable on SNPS: Stifel, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Synopsys still worth investing in?

It depends on the gap between the price ($465) and its estimated value: analysts target $573 on median (+23%), with 70% buys (most reliable on SNPS: Stifel, 100%). Cross-check with their real reliability on SNPS and the cautions above. Information, not advice.

What's the main risk in buying SNPS?

The consensus is not unanimous: of 10 ratings, 2 are neutral and 1 is a sell.

→ Go deeper: the full Synopsys profile (consensus, analyst reliability, price target, performance).